Skip to content

BIVIT

Active Public limited companyfounded 1989active for 36 yearsWestlaan 14, 8560 WevelgemKBO/BCE: BE 0439.165.025 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 36 filings since 1990
peak of €3.1m in 2025
€3.1m▲ 1.1%
peak of €586,493 in 2021
€368,404▼ 6.1%
peak of €950,710 in 2018
€780,157▲ 0.1%
€3.6m▲ 7.1%
peak of 23.7 FTE in 2024
23.5 FTE▼ 0.8%
Board1 name since 2011
1 director
Owners
99%
Documentsfilings and deeds
30-07-20261 day before the deadline
2025abbreviated format
Dividend €368,000Investments €611,567

Key points

from the 2025 annual accounts

Equity

€780,157 ▲ 0.1%
779,7542024+368,404Profit-368,000Dividend780,1572025

BIVIT paid out €368,000 in dividends. That is 100% of the 2025 profit.

Debts

€3.6m 82% of the balance sheet
Financial debts 24%Suppliers 50%Taxes and wages 9%Other 18%

€880,000 of the debts are secured on the company's own assets. In 2022 that was €400,000.

Investments

€601,185 3.1 times depreciation
20212022202320242025

Green is investment, beige is depreciation. Machinery stands 183.1% higher than in 2024.

Staff

24 employees on 31-12-2025
8920211072022652024332025

In 2025, 3 employees joined and 3 left.

Filings

36 annual accounts since 1990
AprilJune31 JulyOctober1990200020102020

Three of the last ten came late. The 2019 accounts came in latest, 33 days after the end of the period.

Position in the sector

€368,404

Higher net result than 84% of companies in pharmaceuticals. The sector median is -€4,260, over 84 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,615 companies had the same profile as BIVIT has now. Each dot stands for 7 companies, two years later.

97.3%
were still trading
2.0%
stopped another way
0.7%
went bankrupt
  • Small
  • 20 years or older
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,615 companies, not a prediction for BIVIT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Chair,
  • 99%score equity €2.9m (2025) · annual accounts 30-09-2025 of
Board & ownership

Recent changes

Environmental permit granted New advertising · decided by Wevelgem
Registered in the Peppol Directory Reachable for e-invoices through 0208:0439165025
appointed as director General meeting of 22-03-2021 · Gazette deed
New sole director appointed, resigned · acts as permanent representative · General meeting of 11-09-2020 · Gazette deed
All 52 events

Comparable companies

same main activity, similar in size and age
Company
BIVIT Wevelgem €4.4m €3.1m 17.8% 23.5
ASTEL MEDICA Neupré €2.6m €2.1m 53.2% 14.6
TRUVION HEALTHCARE Temse €3.2m €1.6m 41.4% 10.1
Advanced Practical Diagnostics Turnhout €4.5m €2.3m 55.5% 12.3
Jeandarme Sint-Truiden €1.6m €0.8m 11.7% 7
BETAPLUS PHARMA Woluwe-Saint-Lambert €24.9m €2.7m 89.8% 11.3
CRESSANA Zwalm €3.3m €1.5m 84.1% 4.4

These companies have the same main activity as BIVIT: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €1.6m and €25m, founded between 1974 and 2008.

Official details

Source: KBO
Status
Active since 21-12-1989Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201and 1 other
Joint committee
220White-collar workers in the food industry · annual accounts 2025
Establishment unit
2.046.216.9788560 Wevelgem, registered on 29-12-1989
Financial year end
31 December
Peppol
Reachable since 14-07-2025
Company details

Annual accounts 2025

≈ €5.3mestimated
€4.4m▲ 5.7%
Employeeson 31-12-2025
24=
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on BIVIT

BIVIT files the abbreviated format. That format states no turnover. The gross margin rose from €977,400 in 2006 to €3.1m in 2025.

holds 99% of the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BIVIT

What is the company number of BIVIT?
The company number of BIVIT is 0439.165.025. The VAT number is the same number with BE in front: BE 0439.165.025.
Where is BIVIT based?
The registered office is at Westlaan 14, 8560 Wevelgem.Company details
What does BIVIT do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
What is the legal form of BIVIT?
BIVIT is a public limited company (NV).
When was BIVIT founded?
BIVIT was founded on 21-12-1989.
Is BIVIT still active?
Yes, BIVIT is an active enterprise in the KBO register.
How many employees does BIVIT have?
BIVIT had an average of 23.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does BIVIT fall under?
In its 2025 annual accounts, BIVIT states joint committee 220 (White-collar workers in the food industry).
What is the turnover of BIVIT?
The turnover in financial year 2025 is about €5.3m. This figure is estimated from the gross margin of €3.1m and 1,577 comparable companies of the same size. It probably lies between €3.6m and €8.7m. It is a rough estimate.
Is BIVIT profitable?
In financial year 2025, BIVIT made a profit of €368,404.
Where can I find the annual accounts of BIVIT?
BIVIT filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIVIT due?
BIVIT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.